Raymond James Financial Services Advisors, Inc. Axsome Therapeutics, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 15,379 shares of AXSM stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,379
Previous 15,627
1.59%
Holding current value
$1.59 Million
Previous $1.26 Million
9.86%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AXSM
# of Institutions
328Shares Held
37.8MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$432 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$412 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$340 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$243 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$108 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.42B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...